RWA
ABBV icon

Redhawk Wealth Advisors’s AbbVie ABBV Stock Holding History

Redhawk Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Sell
3,002
-159
-5% -$34.2K 0.07% 210
2026
Q1 		$688K Sell
3,161
-1
-0% -$222 0.08% 200
2025
Q4 		$722K Buy
3,162
+47
+2% +$10.7K 0.08% 194
2025
Q3 		$721K Buy
3,115
+32
+1% +$6.52K 0.08% 193
2025
Q2 		$572K Sell
3,083
-32
-1% -$5.95K 0.07% 196
2025
Q1 		$653K Buy
3,115
+570
+22% +$111K 0.09% 173
2024
Q4 		$452K Sell
2,545
-64
-2% -$11.8K 0.06% 201
2024
Q3 		$515K Buy
2,609
+78
+3% +$14.6K 0.07% 193
2024
Q2 		$434K Sell
2,531
-135
-5% -$22.4K 0.07% 201
2024
Q1 		$486K Sell
2,666
-4
-0.1% -$689 0.08% 197
2023
Q4 		$414K Buy
2,670
+6
+0.2% +$875 0.08% 195
2023
Q3 		$397K Buy
2,664
+332
+14% +$48.7K 0.13% 135
2023
Q2 		$314K Sell
2,332
-8,971
-79% -$1.32M 0.1% 151
2023
Q1 		$1.8M Buy
11,303
+376
+3% +$57.5K 0.61% 38
2022
Q4 		$1.77M Buy
10,927
+7,134
+188% +$1.09M 0.69% 30
2022
Q3 		$509K Sell
3,793
-5,357
-59% -$769K 0.22% 104
2022
Q2 		$1.4M Buy
9,150
+1,836
+25% +$281K 0.64% 32
2022
Q1 		$1.19M Buy
7,314
+3,985
+120% +$579K 0.31% 62
2021
Q4 		$451K Buy
3,329
+897
+37% +$106K 0.12% 122
2021
Q3 		$262K Buy
2,432
+378
+18% +$43.2K 0.07% 182
2021
Q2 		$231K Sell
2,054
-5,664
-73% -$638K 0.05% 217
2021
Q1 		$835K Buy
7,718
+302
+4% +$32.3K 0.21% 93
2020
Q4 		$795K Sell
7,416
-703
-9% -$67.6K 0.2% 86
2020
Q3 		$711K Buy
8,119
+2,314
+40% +$218K 0.21% 92
2020
Q2 		$570K Buy
5,805
+1,758
+43% +$155K 0.2% 82
2020
Q1 		$308K Buy
+4,047
New +$345K 0.14% 115
2019
Q3 		– Sell
-100
Closed -$7K – 137
2019
Q2 		$7K Buy
+100
New +$7.86K ﹤0.01% 401

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Redhawk Wealth Advisors's ABBV Position: Q2 2026 in Review

Redhawk Wealth Advisors reduced its AbbVie (ABBV) stake by 5% in Q2 2026, selling an estimated $34.2K and leaving 3,002 shares worth $755K. The position accounts for 0.07% of the portfolio, ranked #210.

Redhawk Wealth Advisors first reported a position in ABBV in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.8M in Q1 2023. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Redhawk Wealth Advisors held 3,002 shares of AbbVie worth $755K as of Q2 2026.
  • Redhawk Wealth Advisors sold 159 AbbVie shares in Q2 2026, an estimated $34.2K.
  • AbbVie made up 0.07% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #210 holding.
  • Redhawk Wealth Advisors first reported a position in AbbVie in Q2 2019 and has held it in 27 quarters since.
  • Redhawk Wealth Advisors's AbbVie position peaked at $1.8M in Q1 2023.
  • 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.